Author:
Boratto Fernanda A.,Lages Eduardo B.,Loures Cristina M.C.,Sabino Adriano P.,Malachias Angelo,Townsend Danyelle M.,Branco De Barros Andre Luis,Miranda Ferreira Lucas Antonio,Amaral Leite Elaine
Subject
Pharmacology,General Medicine
Reference30 articles.
1. Synergistic activation of doxorubicin against cancer: a review;Wakharde;Am. J. Clin. Microbiol Antimicrob.,2018
2. Doxil® – the first FDA-approved nano-drug: Lessons learned;Barenholz;J. Control. Release,2012
3. Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems;Tacar;J. Pharm. Pharmacol.,2012
4. Therapeutic nanoparticles in clinics and under clinical evaluation;Schutz;Nanomedicine,2013
5. Doxorubicin: nanotechnological overviews from bench to bedside;Cagel;Drug Discov. Today,2016
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献